Tag: OUNJ
Real-World Weight Loss With Semaglutide, Tirzepatide Less Than That Seen in Clinical Trials
In real-world cohort, percentage weight reduction at one year was 3.6, 6.8, and 11.9 percent with early and late discontinuation and nondiscontinuation, respectively
